Adagio Medical Holdings Files for IPO
Ticker: ADGM · Form: S-1 · Filed: Sep 13, 2024 · CIK: 2006986
| Field | Detail |
|---|---|
| Company | Adagio Medical Holdings, INC. (ADGM) |
| Form Type | S-1 |
| Filed Date | Sep 13, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.0001, $0.01, $10.00, $7.10, $24.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo, medical-devices, registration-statement
TL;DR
Adagio Medical Holdings is going public, get ready for some medical device IPO action.
AI Summary
Adagio Medical Holdings, Inc. filed an S-1 form on September 13, 2024, indicating its intention to go public. The company, formerly known as Aja Holdco, Inc. until January 4, 2024, is based in Laguna Hills, California, and operates in the surgical and medical instruments sector. This filing is a precursor to an Initial Public Offering (IPO), allowing the company to raise capital.
Why It Matters
This S-1 filing signals Adagio Medical Holdings' move towards becoming a publicly traded company, which could lead to increased investment and growth in the medical device sector.
Risk Assessment
Risk Level: medium — As a company filing for an IPO, Adagio Medical Holdings is in a pre-revenue or early-stage growth phase, which inherently carries higher risks than established public companies.
Key Numbers
- 333-282125 — SEC File Number (Identifies this specific SEC filing)
- 0002006986 — Central Index Key (Unique identifier for Adagio Medical Holdings, Inc. in SEC filings)
Key Players & Entities
- Adagio Medical Holdings, Inc. (company) — Filer of the S-1 document
- Aja Holdco, Inc. (company) — Former name of Adagio Medical Holdings, Inc.
- 20240913 (date) — Filing date of the S-1 document
- 20240104 (date) — Date of name change from Aja Holdco, Inc. to Adagio Medical Holdings, Inc.
- Laguna Hills, CA (location) — Business and mailing address of Adagio Medical Holdings, Inc.
FAQ
What is the primary purpose of this S-1 filing?
The primary purpose of this S-1 filing by Adagio Medical Holdings, Inc. is to register its securities for an initial public offering (IPO), allowing it to raise capital by selling shares to the public.
When was Adagio Medical Holdings, Inc. formerly known as?
Adagio Medical Holdings, Inc. was formerly known as Aja Holdco, Inc., with the name change occurring on January 4, 2024.
What industry does Adagio Medical Holdings, Inc. operate in?
Adagio Medical Holdings, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, with a Standard Industrial Classification code of 3841.
Where is Adagio Medical Holdings, Inc. located?
Adagio Medical Holdings, Inc. is located at 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653.
What is the filing date of this S-1 document?
This S-1 document was filed on September 13, 2024.
Filing Stats: 4,648 words · 19 min read · ~15 pages · Grade level 18.1 · Accepted 2024-09-13 17:29:15
Key Financial Figures
- $0.0001 — 32,993,796 shares of our common stock, $0.0001 par value per share (the " Common Stock
- $0.01 — Common Stock, with an exercise price of $0.01 per share (the " Pre-Funded Warrants ")
- $10.00 — Common Stock, with an exercise price of $10.00 per share (the " PIPE Warrants "), in e
- $7.10 — at an effective price of approximately $7.10 per PIPE Share and/or Pre-Funded Warran
- $24.00 — Common Stock, with an exercise price of $24.00 per share, subject to adjustment as pro
- $0.007 — at an effective price of approximately $0.007 per share and exchanged for shares of C
- $9.23 — ty consideration value of approximately $9.23 per share and 30,000 shares of Common S
- $1.67 — ating Officer with an exercise price of $1.67 per share. The selling stockholders m
- $11.56 — at a redemption price of approximately $11.56 per share, for an aggregate redemption
- $31,312,102 — gate redemption amount of approximately $31,312,102. The shares of Common Stock being offer
- $3.85 — he closing price of our Common Stock of $3.85 as of September 12, 2024, upon the sale
- $3.25 — ay experience a potential loss of up to $3.25 per PIPE Share, PIPE Warrant Share and
- $6.15 — ay experience a potential loss of up to $6.15 per Convertible Note Share and $20.15 p
- $20.15 — to $6.15 per Convertible Note Share and $20.15 per Convert Warrant Share, (c) the Spon
- $3.84 — nce a potential profit of approximately $3.84 per Sponsor Class A Conversion Share an
Filing Documents
- adgm-20240630xs1.htm (S-1) — 7891KB
- adgm-20240630xex5d1.htm (EX-5.1) — 26KB
- adgm-20240630xex23d2.htm (EX-23.2) — 4KB
- adgm-20240630xex23d3.htm (EX-23.3) — 4KB
- adgm-20240630xex23d4.htm (EX-23.4) — 4KB
- adgm-20240630xexfees.htm (EX-FILING FEES) — 58KB
- adgm-20240630xex5d1001.jpg (GRAPHIC) — 5KB
- adgm-20240630xs1024.jpg (GRAPHIC) — 23KB
- adgm-20240630xs1026.jpg (GRAPHIC) — 25KB
- adgm-20240630xs1028.jpg (GRAPHIC) — 48KB
- adgm-20240630xs1030.jpg (GRAPHIC) — 63KB
- adgm-20240630xs1031.jpg (GRAPHIC) — 26KB
- adgm-20240630xs1032.jpg (GRAPHIC) — 17KB
- adgm-20240630xs1033.jpg (GRAPHIC) — 49KB
- adgm-20240630xs1035.jpg (GRAPHIC) — 33KB
- adgm-20240630xs1036.jpg (GRAPHIC) — 40KB
- adgm-20240630xs1037.jpg (GRAPHIC) — 45KB
- adgm-20240630xs1038.jpg (GRAPHIC) — 40KB
- adgm-20240630xs1040.jpg (GRAPHIC) — 29KB
- adgm-20240630xs1041.jpg (GRAPHIC) — 65KB
- adgm-20240630xs1042.jpg (GRAPHIC) — 36KB
- adgm-20240630xs1044.jpg (GRAPHIC) — 44KB
- adgm-20240630xs1052.jpg (GRAPHIC) — 10KB
- 0001104659-24-099872.txt ( ) — 37209KB
- adgm-20240630.xsd (EX-101.SCH) — 198KB
- adgm-20240630_cal.xml (EX-101.CAL) — 97KB
- adgm-20240630_def.xml (EX-101.DEF) — 1611KB
- adgm-20240630_lab.xml (EX-101.LAB) — 975KB
- adgm-20240630_pre.xml (EX-101.PRE) — 2144KB
- adgm-20240630xs1_htm.xml (XML) — 4948KB
Risk Factors
Risk Factors 14 Market and Industry Data 56
Use of Proceeds
Use of Proceeds 57 Determination of Offering Price 58 Market Information for Securities and Dividend Policy 59 Unaudited Pro Forma Condensed Combined Financial Information 60
Management's Discussion and Analysis of Financial Condition and Results of Operations of ARYA
Management's Discussion and Analysis of Financial Condition and Results of Operations of ARYA 84
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Medical
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Medical 100
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Holdings
Management's Discussion and Analysis of Financial Condition and Results of Operations of Adagio Holdings 118
Business
Business 120 Management 151
Executive Compensation
Executive Compensation 158 Certain Relationships and Related Party Transactions 164 Principal Stockholders 167 Selling Stockholders 169 Description of our Securities 173 Material U.S. Federal Income Tax Consequences 179 Plan of Distribution 182 Legal Matters 184 Experts 184 Where You Can Find More Information 185 You should rely only on the information contained in this prospectus, any supplement to this prospectus or in any free writing prospectus, filed with the Securities and Exchange Commission. Neither we nor the selling stockholders have authorized anyone to provide you with additional information or information different from that contained in this prospectus filed with the Securities and Exchange Commission. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The selling stockholders are offering to sell, and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our securities. Our business, financial condition, results of operations and prospects may have changed since that date. For investors outside of the United States: Neither we nor the selling stockholders, have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our securities and the distribution of this prospectus outside the United States. 4 Table of Contents FREQUENTLY USED TERMS " Adagio Holdings " or " Company " means Adagio Medical Holdings, Inc., a Delaware corporation,